Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL. (Q39400792)

11 September 2017

Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL. (English)

1 reference

11 September 2017

1 reference

1 reference

G L Robinson

1

1 reference

11 September 2017

D Dinsdale

series ordinal

2

1 reference

11 September 2017

M Macfarlane

series ordinal

3

1 reference

11 September 2017

K Cain

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

6 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

4996-5006

1 reference

11 September 2017

48

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.13

11 September 2017

0 references

cites work

Molecular imaging of cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

The mitochondrial apoptosome: a killer unleashed by the cytochrome seas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

The Apaf-1 apoptosome: a large caspase-activating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Following TRAIL's path in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

A systematic approach to protein glycosylation analysis: a path through the maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Sugar-free approaches to cancer cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

New roles for the LKB1-->AMPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Ultrastructure of the mitochondrion and its bearing on function and bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Recombinant TRAIL and TRAIL receptor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Barriers to effective TRAIL-targeted therapy of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

Incorporation of glucose into glycogen in primary cultures of rat hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.13

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.13

1 reference

11 September 2017

1 reference